# FDA panel narrowly backs unapproved peptide drug - timesdaily.com

*Источник: timesdaily.com*
*Дата: 2026-07-24*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxOVVc0ZmE3ZldIUUpLbmFkZk5OQUxQVk5XNEJ0QW1ZMk9fNm54VDZKWVFEWXRsMU41b2tvemljb3lUNzZJbDl2d3Q0MHo5YjVrdm5qSTFNLUM3Zy1ja0RPWDBoclZpZ28tSjBSSjJ0S0dySmJFYWhHT29reGxxdlF1UXdRbThlV2xPUTVrUnRDZU1FR0VYTVdGdmxVblpfVVU3OHVGYkVHMFcwWmRMNUwwblBKY1VCNXlrWWRFMFVNS1F1Wkc0X3Y3Zi1ibkc5X1ZIeF9j?oc=5" target="_blank">FDA panel narrowly backs unapproved peptide drug</a>&nbsp;&nbsp;<font color="#6f6f6f">timesdaily.com</font>

[Оригинал](https://www.timesdaily.com/life/health/fda-panel-narrowly-backs-unapproved-peptide-drug/article_fa19346f-7bcf-4b91-9bca-8b62239cf604.html)